Braster and Labstix Diagnostics Pty, one of the leading distributors of medical devices in South Africa, have concluded a distribution agreement for the sale and distribution of the Braster Professional device in South Africa, Braster announced in a statement.
The agreement provides for cooperation in the scope of importing and selling Braster devices together with research packages. According to the contract, it enters into force upon signature by both parties and is concluded for a period of three years from the date of conclusion.
Braster is the only company in the world that has proven technology for the production of liquid crystal matrices, on the basis of which it developed a prototype Braster Tester – an innovative medical thermographic tester used for early detection of breast pathology, in particular breast cancer. The company has been listed on the main WSE market since 2015.